Our Commitment

At Britannia, we work with specialist focus groups and fund clinical trials to ensure that treatment programmes are optimised and that quality of life is improved.

Britannia Pharmaceuticals Ltd. is committed to ensuring that any clinical trial we fund is patient centric and centred around improving quality of life in our therapeutic focus area.



A Phase III, Multi-centre, double blind, placebo controlled study enrolling 102 advanced Parkinson’s patients.